nach oben

Heart Failure Reviews

Erschienen in:

01.09.2009

An integrated approach to managing sleep disordered breathing and cardiovascular disease

verfasst von: Robin J. Trupp, Elizabeth J. Corwin

Erschienen in: Heart Failure Reviews | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Despite its prevalence, most cases of sleep disordered breathing (SDB) go unrecognized by the medical community, creating a mismatch between disease pervasiveness and medical appreciation of its impact. Of particular importance is that 30% of those with cardiovascular disease (CVD) have some type of sleep disorder. One explanation for this lack of recognition and under-appreciation is that common symptoms seen with SDB are non-specific and are present in many acute and chronic conditions. This article will present a brief review of current processes used to diagnose and treat SDB, followed by a discussion of the overlap that exists between CVD and SDB, and present an argument that these chronic conditions should not be considered and managed as separate entities.

Ancoli-Israel S (2006) The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness. Am J Manag Care 12:S221–S229PubMed

Trupp R, Hardesty P, Osbourne J et al (2004) Prevalence of sleep disordered breathing in a heart failure program. Congest Heart Fail (Greenwich, Conn.) 10:217–220CrossRef

Lanfranchi P, Somers V (2003) Sleep-disordered breathing in heart failure: characteristics and implications. Respir Physiol Neurobiol 136:153–165. doi:10.1016/S1569-9048(03)00078-8 PubMedCrossRef

Peppard P, Young T, Palta M et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384. doi:10.1056/NEJM200005113421901 PubMedCrossRef

Paul S (1997) Implementing an outpatient congestive heart failure clinic: the nurse practitioner role. Heart Lung 26:486–491. doi:10.1016/S0147-9563(97)90042-X PubMedCrossRef

Fonarow GC, Stevenson LW, Walden JA et al (1997) Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 30:725–732. doi:10.1016/S0735-1097(97)00208-8 PubMedCrossRef

Whellan D et al (2005) Metaanalysis and review of heart failure disease management randomized controlled clinical studies. Am Heart J 149(4):722–729. doi:10.1016/j.ahj.2004.09.023 PubMedCrossRef

Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001) Impairment of vascular endothelial function and left ventricular filling: associated with the severity of apnea-induced hypoxemia during sleep. Chest 119:1085–1089. doi:10.1378/chest.119.4.1085 PubMedCrossRef

Meier-Ewert H, Ridker P, Rifai N, Regan M, Price N, Dinges D (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43:678–683. doi:10.1016/j.jacc.2003.07.050 PubMedCrossRef

10.

Young T, Evans L, Finn L, Palta M (1997) Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20:705–706PubMed

11.

Netzer N, Stoohs R, Netzer C, Clark K, Strohl K (1999) Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:488

12.

Johns M (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. Chest 103:130–136. doi:10.1378/chest.103.1.30 CrossRef

13.

Continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) Available at http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM6048.pdf. Accessed 15 Aug 2008

14.

Rodway GW, Sanders MH (2003) The efficacy of split-night sleep studies. Sleep Med Rev 7:301–401. doi:10.1053/smrv.2002.0272 CrossRef

15.

Sanders MH, Costantino JP, Strollo PJ et al (2000) The impact of split-night polysomnography or diagnosis and positive pressure therapy titration on treatment acceptance and adherence in sleep apnea/hypopnea. Sleep 23:17–24

16.

Flemons WW, Douglas NJ, Kuna ST et al (2004) Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med 169:668–672. doi:10.1164/rccm.200308-1124PP PubMedCrossRef

17.

Pack AI (2004) Sleep disordered breathing: access is the issue. Am J Respir Crit Care Med 169:666–667. doi:10.1164/rccm.2401008 PubMedCrossRef

18.

Buchner NJ, Sanner BM, Borgel J, Rump LC (2007) CPAP treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 176:1274–1280. doi:10.1164/rccm.200611-1588OC PubMedCrossRef

19.

Kaneko Y, Floras J, Phil D et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMed

20.

Peker Y, Hedner J, Johansson A, Bende M (1997) Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea with nasal CPAP treatment. Am Sleep Disorders Sleep Research Soc 20:645–653

21.

Kribbs NB, Pack AI, Kline LR et al (1986) Effects of one night without nasal CPAP therapy for sleep apnea. Chest 90:330–333CrossRef

22.

Kribbs N, Pack A, Kline L et al (1986) Effects of one night without CPAP therapy for sleep apnea. Chest 90:330–333. doi:10.1378/chest.90.3.330 CrossRef

23.

Zozula R, Rosen R (2001) Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 7:391–398. doi:10.1097/00063198-200111000-00005 PubMedCrossRef

24.

Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P (1995) Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 107:375–381. doi:10.1378/chest.107.2.375 see commentsPubMedCrossRef

25.

McArdle N, Devereuz G, Heidarnejad H et al (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159(4):1108–1114PubMed

26.

Weaver T, Kribbs N, Pack A et al (1997) Night-to-night variability in CPAP use over the first three months of treatment. Sleep 20:278–283PubMed

27.

Engleman H, Martin S, Douglas N (1994) Compliance with CPAP therapy in patients with the sleep apnea/hypopnea syndrome. Thorax 49:263–266PubMedCrossRef

28.

Hoy CJ, Vannelle M, Kingshott RN, Engleman HM, Douglas NJ (1999) Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 159:1096–1100PubMed

29.

Weaver T, Maislin G, Dinges D et al (2003) Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, volition to use continuous positive airway pressure. Sleep 26(6):727–732PubMed

30.

Lewis KE, Seale L, Bartie IE, Watkins AJ, Ebden P (2004) Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 27:134–138PubMed

31.

Stepnowsky C, Bardwell W et al (2002) Psychologic correlates of compliance with continuous positive airway pressure. Sleep 25:758–762PubMed

32.

Chediak AD (2008) Why CMS approved home sleep testing for CPAP coverage. J Clin Sleep Med 4(1):16–18PubMed

33.

Parthasarathy S, Haynes PL, Budhiraja R et al (2006) A national survey of the effect of sleep medicine specialists and American Academy of Sleep Medicine Accreditation on management of obstructive sleep apnea. J Clin Sleep Med 2:499–521

34.

Collop NA, Anderson WD, Boehlecke B et al (2007) Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med 3(7):737–747PubMed

35.

Minoguchi K, Tazaki T, Yokoe T et al (2004) Elevated production of tumor necrosing factor by monocytes in patients with obstructive sleep apnea syndrome. Chest 126:1473–1479. doi:10.1378/chest.126.5.1473 PubMedCrossRef

36.

Phillips B, Kato M, Narkiewicz K, Choe I, Somers V (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 279:H234–H237

37.

Phillips B, Narkiewicz K, Pesek C, Haynes W, Dyken M, Somers V (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66PubMed

38.

Spiegel K, Tasali , Penev P, Cauter EV (2004) Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. An Int Med 141:846–850

39.

Chobanian AV, Bakris GI, Black HR et al (2003) The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 Report. J Am Med Assoc 289:2560–2572. doi:10.1001/jama.289.19.2560 CrossRef

40.

National Kidney Foundation (2008) Kidney disease outcomes quality initiative. Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Guideline 1. Goals of antihypertensive therapy in CKD. Available at http://www.kidney.org/professionals/KDOQI/guidelines_bp/guide_1.htm. Accessed 1 March 2008

41.

Grundy SM, Cleeman JI, Merz NB et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program adult treatment panel III guidelines. Circulation 110:227–239. doi:10.1161/01.CIR.0000133317.49796.0E PubMedCrossRef

42.

Adams HP, del Zoppo G, Alberts MJ et al (2007) Guidelines for the early management of adults with ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 38(9):e96. doi:10.1161/STROKEAHA.107.181486 CrossRef

43.

Hunt S, Abraham W, Chin M et al (2005) Diagnosis and management of chronic heart failure in the adult. Circulation 112(12): e154–e235PubMedCrossRef

44.

Adams K, Arnold J, Baker D et al (2006) Executive summary: HFSA 2006 comprehensive heart failure practice guidelines. J Card Fail 12(1):10–38. doi:10.1016/j.cardfail.2005.12.001 CrossRef

45.

Merriam-Websters. Available at http://www.merriam-webster.com/dictionary/collaborate

46.

Stein-Parbury J, Liaschenko J (2007) Understanding collaboration between nurses and physicians as knowledge at work. Am J Crit Care 16(5):471–477

47.

McAlister F, Stewart S, Ferrua S, McMurray JJV (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for readmission: a systematic review of randomized trials. J Am Coll Cardiol 44:810–819PubMed

48.

Trupp RJ, Corwin EJ (2008) Sleep disordered breathing, cognitive dysfunction and adherence in heart failure: linked through pathology? Prog Cardiovasc Nurs 23(1):32–36. doi:10.1111/j.1751-7117.2008.08000.x PubMed

49.

Chung SA, Jairam S, Hussain MR, Shapiro CM (2001) Knowledge of sleep apnea in a sample grouping of primary care physicians. Sleep Breath 5:115–121. doi:10.1055/s-2001-17429 PubMedCrossRef

50.

Haponik EF, Frye AW, Richards B et al (1996) Sleep history is neglected diagnostic information: challenges for primary care physicians. J Gen Intern Med 11:759–761. doi:10.1007/BF02598994 PubMedCrossRef

51.

Roccaforte R, Demers C, Baldassare F et al (2005) Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 7:1113–1144. doi:10.1016/j.ejheart.2005.08.005 CrossRef

Titel: An integrated approach to managing sleep disordered breathing and cardiovascular disease
verfasst von: Robin J. Trupp
Elizabeth J. Corwin
Publikationsdatum: 01.09.2009
Verlag: Springer US
Erschienen in: Heart Failure Reviews / Ausgabe 3/2009
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-008-9117-7

Neu im Fachgebiet Kardiologie

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

An integrated approach to managing sleep disordered breathing and cardiovascular disease

Abstract

Neu im Fachgebiet Kardiologie

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

Weniger Extremitätenischämien mit dualer Plättchenhemmung

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Kardiologie

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

Central sleep apnea in patients with congestive heart failure

Treatment of sleep disordered breathing in congestive heart failure

Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease

Insomnia and chronic heart failure

Sleep-associated movement disorders and heart failure

Sleep-disordered breathing in patients with decompensated heart failure

Neu im Fachgebiet Kardiologie

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

Weniger Extremitätenischämien mit dualer Plättchenhemmung

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Kardiologie